The Global Vaccines Innovation and Immunology Conference, a hybrid event taking place from September 21-23, 2026, in London, UK and online aims to be a central platform for unveiling the latest discoveries and developments in the field of vaccinology. The event emphasizes the critical role of vaccine innovation in protecting global health and combating infectious diseases. From foundational vaccine science to the newest technologies in vaccine delivery, attendees will gain insights into the advancements poised to shape healthcare in the coming decades. Participants can look forward to sessions covering a diverse range of topics, including next-generation vaccine design, strategies for enhancing vaccine efficacy and durability, and solutions for equitable distribution. Special focus will be given to mRNA and viral vector vaccines that have transformed public health responses, as well as novel adjuvants and delivery systems that enhance immune responses and improve vaccine stability. Attendees will also explore the ongoing efforts to address vaccine hesitancy, particularly through community engagement and transparent communication strategies. With a hybrid format, the conference ensures accessibility and engagement for both on-site and virtual participants, creating a truly global dialogue.